Patients should discuss eligibility for these treatments with their GP or a specialist obesity service, as access criteria, commissioning arrangements, and availability vary across NHS regions
[4] The most frequently reported adverse effects include transient gastrointestinal discomfort-nausea, vomiting, abdominal cramps, or diarrhea-particularly when large doses are delivered rapidly
Join our newsletter and be prepared for exciting promotions.
Heres a breakdown of your 2026 coverage
Heres how: Decreases appetite: Semaglutide acts on parts of the brain that control hunger
While we have explored several mechanisms by which CR could influence mental health, there remains vast potential for expanding the pathways of next-generation CRMs